Is the exosome a potential target for cancer immunotherapy?

Affiliations

Editorial

Akihiko Yoshimura et al. Ann Transl Med. 2017 Mar.

. 2017 Mar;5(5):117.

doi: 10.21037/atm.2017.01.47.

¹ Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Increasing the immune activity of exosomes: the effect of miRNA-depleted exosome proteins on activating dendritic cell/cytokine-induced killer cells against pancreatic cancer.
Que RS, Lin C, Ding GP, Wu ZR, Cao LP. Que RS, et al. J Zhejiang Univ Sci B. 2016 May;17(5):352-60. doi: 10.1631/jzus.B1500305. J Zhejiang Univ Sci B. 2016. PMID: 27143262 Free PMC article.

1. Zhang X, Pei Z, Chen J, et al. Exosomes for Immunoregulation and Therapeutic Intervention in Cancer. J Cancer 2016;7:1081-7. 10.7150/jca.14866 - DOI - PMC - PubMed
1. Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev 2013;32:623-42. 10.1007/s10555-013-9441-9 - DOI - PMC - PubMed
1. Fujita Y, Yoshioka Y, Ochiya T. Extracellular vesicle transfer of cancer pathogenic components. Cancer Sci 2016;107:385-90. 10.1111/cas.12896 - DOI - PMC - PubMed
1. Greening DW, Gopal SK, Xu R, et al. Exosomes and their roles in immune regulation and cancer. Semin Cell Dev Biol 2015;40:72-81. 10.1016/j.semcdb.2015.02.009 - DOI - PubMed
1. Peinado H, Alečković M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012;18:883-91. 10.1038/nm.2753 - DOI - PMC - PubMed